Bioarray
Bioarray is a private Spanish molecular diagnostics company headquartered in Elche, Spain, founded in 2008. With 11-50 employees, its stated mission is to provide molecular diagnosis of genetic diseases, serving healthcare providers and patients in the clinical genetics segment.
- Company typePrivate
- Founded2008
- HeadquartersElche, Spain
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Bioarray does
Bioarray is a private Spanish biotechnology company headquartered in Elche, Spain, founded in 2008 and operating with a headcount of 11-50 employees. Its self-stated mission is to provide molecular diagnosis of genetic diseases, positioning it within the clinical molecular diagnostics segment and implying a customer base of healthcare providers, clinical laboratories, and patients with suspected hereditary conditions.
The company's website (bioarray.es) returned only a loader/verification page during data collection, and no information on core products, assay or platform technology, service catalog, regulatory certifications, or pricing structure is documented in the available source material. There is no disclosed funding history, leadership roster, scientific advisory board, partnership ecosystem, patent portfolio, or customer reference list.
No revenue, headcount trend, geographic footprint beyond Elche, or commercial pipeline data is available, so the company's scale, growth posture, and competitive positioning within the Spanish and broader European molecular diagnostics market cannot be assessed from the present evidence base.
Bioarray firmographics
Firmographics- Name
- Bioarray
- Website
- https://bioarray.es
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bioarray is a private Spanish molecular diagnostics company headquartered in Elche, Spain, founded in 2008. With 11-50 employees, its stated mission is to provide molecular diagnosis of genetic diseases, serving healthcare providers and patients in the clinical genetics segment.
- Ownership category
- akta.pro rank
Bioarray industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
- akta.pro secondary industries
- Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)
Keywords
Where Bioarray is headquartered
LocationHeadquarters
- HQ city
- Elche
- HQ country
- Spain
- HQ region
- Europe
Markets served
Bioarray business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Bioarray product offering
Product offeringCore offering
Bioarray provides molecular diagnosis of genetic diseases. The company operates as a small laboratory services provider focused on identifying and characterizing hereditary and genetic disorders through molecular-level testing. Specific assay menus, panels, or service workflows are not detailed in the available source material.
Differentiator
Problem solved
Functional benefit
Companies that use Bioarray
Customer profileIdeal customer profiles1 record
Bioarray technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bioarray competitors and assessment
Company assessmentBroad incumbents
- Natera: US molecular diagnostics company offering cell-free DNA, reproductive, and oncology genetic testing. Operates in overlapping molecular diagnostic categories but with far greater scale and commercial reach than Bioarray.
- Myriad Genetics: Large US molecular diagnostics company with a broad hereditary disease, oncology, and pharmacogenomic test menu. Comparable as an established molecular diagnostics incumbent, though significantly larger and broader in scope than Bioarray.
- Eurofins Genomics: European genomics services arm of Eurofins Scientific offering molecular biology, sequencing, and genotyping services. Comparable as a European molecular/genetic testing services provider within a much larger industrial group.
- Invitae: US-based genetic testing company offering a broad menu of molecular diagnostics across hereditary conditions, reproductive health, and oncology. Comparable as a molecular diagnostics provider, though operating at substantially greater scale.
Direct peers
- Centogene: Germany-headquartered rare disease and molecular diagnostics company offering genetic testing and interpretation services. Comparable as a European molecular diagnostics lab focused on hereditary disease, overlapping with Bioarray's core mission.
- Sistemas Genómicos: Spanish molecular genetics laboratory offering cytogenetic and molecular diagnostic services, including hereditary disease testing. Closely comparable to Bioarray as a domestic Spanish peer in molecular genetic diagnostics.
- Reference Laboratory S.L. Spanish reference diagnostics laboratory providing specialized molecular and genetic testing to clinicians and hospitals. Directly comparable as a Spain-based molecular diagnostics service provider.
- Igenomix: Spain-based reproductive and clinical genetics laboratory (now part of Vitrolife) offering molecular diagnostics in reproductive health and hereditary disease. Direct peer due to overlapping molecular genetic testing services and Spanish footprint.
Emerging players
- Veritas Genetics: Genetics company offering whole-genome and molecular genetic testing with a focus on hereditary disease prevention. Comparable as a genetic disease diagnostics player, though focused on whole-genome sequencing rather than array-based testing.
Regional players
- Medicover Genetics: European clinical genetics laboratory (part of Medicover) offering molecular and cytogenetic diagnostic services across Central and Eastern Europe. Comparable as a regional molecular diagnostics provider with a hereditary disease focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks4 records
Key highlights4 records
Customer concentration
Bioarray social profiles
Digital presenceBioarray financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioarray leadership team
Management profileNumber of profiles
Bioarray funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioarray M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioarray
What does Bioarray do?
Bioarray provides molecular diagnosis of genetic diseases. The company operates as a small laboratory services provider focused on identifying and characterizing hereditary and genetic disorders through molecular-level testing. Specific assay menus, panels, or service workflows are not detailed in the available source material.
Is Bioarray a public or private company?
Bioarray is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bioarray founded?
Bioarray was founded in 2008. It employs 11 to 50 people.
Where is Bioarray based?
Bioarray is headquartered in Elche, Spain, in the Europe region.
Who are Bioarray's main competitors?
Broad incumbents on record are Natera, Myriad Genetics, Eurofins Genomics and Invitae. Direct peers are Centogene, Sistemas Genómicos, Reference Laboratory S.L. and Igenomix. Veritas Genetics is listed as an emerging player. Medicover Genetics is listed as a regional player.
Does Bioarray have an API?
No public API is recorded for Bioarray.
What industry is Bioarray in?
Bioarray's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 621511 and its SIC code is 8071.